XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Interim Financial Reporting
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Interim Financial Reporting

Note 1.  Interim Financial Reporting

 

Basis of presentation: Electromed, Inc. (the “Company”) develops, manufactures and markets innovative airway clearance products that apply High Frequency Chest Wall Oscillation (“HFCWO”) therapy in pulmonary care for patients of all ages. The Company markets its products in the U.S. to the home health care and institutional markets for use by patients in personal residences, hospitals and clinics. The Company also sells internationally both directly and through distributors. International sales were approximately $66,000 and $135,000 for the three months ended September 30, 2019 and 2018, respectively. Since its inception, the Company has operated in a single industry segment: developing, manufacturing and marketing medical equipment.

 

The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial statements and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed financial statements reflect all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the Company’s financial position and results of operations as required by Regulation S-X. Interim results of operations are not necessarily indicative of the results that may be achieved for the full year. The financial statements and related notes do not include all information and footnotes required by U.S. GAAP for annual reports. This interim report should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“fiscal 2019”).

 

A summary of the Company’s significant accounting policies follows:

 

Use of estimates: Management uses estimates and assumptions in preparing the condensed financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used. The Company believes the critical accounting policies that require the most significant assumptions and judgments in the preparation of its condensed financial statements include revenue recognition and the related estimation of variable consideration, allowance for doubtful accounts, inventory obsolescence, share-based compensation and the warranty liability.

 

Net income per common share: Net income is presented on a per share basis for both basic and diluted common shares. Basic net income per common share is computed using the weighted average number of common shares outstanding during the period, excluding any restricted stock awards which have not vested. The diluted net income per common share calculation includes outstanding restricted stock grants and assumes that all stock options were exercised and converted into common stock at the beginning of the period, unless their effect would be anti-dilutive. Common stock equivalents excluded from the calculation of diluted earnings per share because their impact was anti-dilutive was 446,350 and 375,750 for the three months ended September 30, 2019 and 2018, respectively.

 

New accounting pronouncements:  In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)” (“ASU 2016-02”).   This standard requires the recognition of all lease transactions on the balance sheet as a lease liability and a right-of-use asset (as defined in ASC 2016-02). ASU 2016-02 to Topic 842 – Leases (“ASC 842”) became effective for the Company on July 1, 2019 and was applied retrospectively to all periods presented.  The Company applied the practical expedient to calculate the present value of the fixed payments without having to perform an allocation to lease and non-lease components.  Additional information and required disclosures are included in Note 9. 

 

Impact on Previously Reported Results:

 

The following table presents a recast of selected unaudited statement of operations line items after giving effect to the adoption of ASC 842:

 

 

 

For the three months ended September 30, 2018

 

 

 

As Previously Reported

 

 

Effect of Adoption

 

 

As Adjusted

 

Net Revenues

 

$

7,275,883

 

 

$

 

 

$

7,275,883

 

Cost of Revenues

 

 

1,733,051

 

 

 

 

 

 

1,733,051

 

Gross Profit

 

 

5,542,832

 

 

 

 

 

 

5,542,832

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

5,275,755

 

 

 

(2,769

)

 

 

5,272,986

 

Research and development

 

 

68,137

 

 

 

 

 

 

68,137

 

Total operating expenses

 

 

5,343,892

 

 

 

(2,769

)

 

 

5,341,123

 

Operating Income

 

 

198,940

 

 

 

2,769

 

 

 

201,709

 

Interest income (expense), net

 

 

13,452

 

 

 

 

 

 

13,452

 

Net income before income taxes

 

 

212,392

 

 

 

2,769

 

 

 

215,161

 

Income tax expense

 

 

58,000

 

 

 

 

 

 

58,000

 

Net Income

 

$

154,392

 

 

$

2,769

 

 

$

157,161

 

Income per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.02

 

 

$

0.00

 

 

$

0.02

 

Diluted

 

$

0.02

 

 

$

0.00

 

 

$

0.02

 

 

The following table presents a recast of selected unaudited balance sheet line items after giving effect to the adoption of ASC 842:

 

 

June 30, 2019

 

 

 

As Previously Reported

 

 

Effect of Adoption

 

 

As Adjusted

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Other Assets

 

 

 

 

 

45,044

 

 

 

45,044

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholder’s Equity

 

 

 

 

 

 

 

 

 

 

 

 

Current maturities of other long-term liabilities

 

 

 

 

 

 

30,320

 

 

 

30,320

 

Other long-term liabilities

 

 

 

 

 

14,737

 

 

 

14,737

 

Retained Earnings

 

 

9,522,076

 

 

 

(12

)

 

 

9,522,064

 

 

The following table presents a recast of selected unaudited statement of cash flow line items after giving effect to the adoption of ASC 842:

 

 

For the three months ended September 30, 2018

 

 

 

As Previously Reported

 

 

Effect of Adoption

 

 

As Adjusted

 

Cash Flow from Operating Activities

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

154,392

 

 

$

2,769

 

 

$

157,161

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Prepaid expenses and other assets

 

 

336,065

 

 

 

45,292

 

 

 

381,357

 

Accounts payable and accrued liabilities

 

 

(103,253

)

 

 

(48,061

)

 

 

(151,314

)